INTRODUCTION
The intracerebral infection of mice with Bordetella pertussis was first suggested by Norton as a result of the successful use of this route with Salmonella typhi (Norton & Dingle, 1935) . The assay of pertussis vaccines using the intracerebral route for the challenge was developed in the U.S.A., particularly by Kendrick and Pittman (Kendrick, Eldering, Dixon & Misner, 1947; U.S., N.I.H., 1948, Minimum Requirements; Pittman, 1956) .
In 1937 Burnet & Timmins (1937) described the intranasal technique for the infection of mice with B. pertussis. For a time it seemed that assays of pertussis vaccines using either route for the challenge were equally valid. Further experience showed that whereas many vaccines successfully pass both tests, certain vaccines pass one test and not the other, and that a series of vaccines might be arranged in quite different orders of potency by the two tests. The antigen responsible for protecting children appears to be that protecting mice against challenge by the intracerebral route and not that protecting mice against a challenge by the intranasal route (Standfast, 1958) . A difference in the antibodies protecting against the two types of challenge was demonstrated in passive protection tests (Dolby & Standfast, 1958) .
In this paper the results obtained by following the course of infection in the brains of untreated, actively immunized and passively protected mice are presented. Protection against an intracerebral infection involves a mechanism quite distinct from the mechanism of protection against an intranasal infection already described (Dolby, Thow & Standfast, 1961) . , , ,.
.
METHODS

Injecting suspensions
Most of the experiments were made with strain no. 18-323 (NCTC 9797) isolated by Dr P. Kendrick. Its LD50 by the intracerebral route is c. 10 20 in mice of strain C1. Only very occasionally are other strains of B. pertussis found of similar intracerebral virulence; for most strains the LD50 lies between 10 206 JEAN M. DOLBY AND A. F. B. STANDFAST Viable counts were made of all suspensions. The viability of the Casamino acid suspensions remained stable for 3 hr. The routine inoculum in assays and protection tests was 50,000 organisms by opacity (total count), of which c. 10 % were viable. This dose contains c. 200 LD50.
Viable counts
At intervals, groups of 5 or 10 mice were killed with coal gas and their brains were removed aseptically. Each brain, treated separately, was placed in 10 ml. 1 % aqueous Difco Casamino acids (commercial grade) in a 2 oz. Universal bottle containing about 2 ml. glass beads (5 mm. diam.) and shaken for 3 min. on a vertical shaker 2 | in. throw, 325 r.p.m. Mice dying from the infection on the day of the count were included. Serial tenfold dilutions were made in 1 % Casamino acids and plated out on Bordet-Gengou plates and counts made by the method of Miles & Misra (1938) . For counts in brains receiving the small infecting doses during the first two days of infection, 0-5 ml. of the homogenate or of a 1/10 dilution were spread over the surface of a Bordet-Gengou plate. The numbers of organisms are expressed as the geometric mean of counts from all the mice within the group.
Passive protection tests
Suitable dilutions of rabbit antisera were given intraperitoneally 4 hr. before the challenge (c. 200 LD50) B. pertussis suspension was given by the intracerebral route (see Dolby & Standfast, 1958) .
Rabbit antisera
Rabbit antisera to bacteria and toxin were prepared as before (Dolby & Standfast, 1958) . In addition, an antiserum was prepared against fraction K l (Dolby, 1958) ; this serum was highly protective against an intracerebral challenge but did not protect against an intranasal challenge. Pure antitoxin was obtained by absorbing a serum prepared against a Hughes press extract of bacilli (Hughes, 1951) with heavy suspensions of formalin-treated whole bacterial cells (after neutralization of excess formalin) until the serum failed to protect mice against infection with living organisms. The absorbed serum neutralized toxin and protected mice against lethal doses of toxin given by the intraperitoneal route.
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A similar system applies to 'intranasal' antigen and 'intranasal' antibody. The route of administration of antigen, challenge or serum is always referred to as the intracerebral route, etc. Abbreviations IC, IN and IP are used for intracerebral, intranasal and intraperitoneal when it is necessary to abbreviate.
RESULTS
The fate of the inoculum in the mouse's brain Strain 18-323 injected by the intracerebral route into mice multiplied without difficulty from small inocula. There was a considerable immediate loss of the inoculum amounting to at least 90 % of the bacteria injected.
Viable counts carried out immediately after the injection of the inoculum, and 2 hr. later showed that the average drop was from 10 ; by 24 hr. growth had brought the count up to a figure similar to the inoculum. The injected dose is referred to as the inoculum. The figure for the 2 hr. count, which was about 10 % of the inoculum, is always referred to as the infecting dose. Cairns (1950) first reported this immediate loss of the greater part of an intracerebral inoculum which he showed spills over into the bloodstream. Dr L. E. Holt (private communication) first drew our attention to the fate of indian ink injected by the intracerebral route in mice; the ink can easily be shown in the ventricles and right down the spinal cord. Mims (1960) deals more fully with the fate of indian ink injected by this route into mice, and describes its distribution in the subarachnoid space, the ventricles and the central canal. . In all the curves the 2 hr. count shows a drop of about 90 %; unfortunately there was no 2 hr. count in the 10 8 ' 6 experiment. In 24 hr. the counts have reached or even passed the original inoculum.
The growth of Bordetella pertussis in the brain
The increase in viable counts for a series of increasing doses of B. pertussis shown in Fig. 2 are of the pooled results of several experiments so that each point is the geometric mean count of at least 30 mice. The counts rise steadily to a value between 10 7 ' 5 and 10 8 , when the mice start to die. The curves indicate a reasonably rapid growth for the first day or so and then a progressive slowing, owing either to increasing immunity or perhaps to exhaustion of nutrients for the bacteria.
In most experiments the rate of increase in viable count was about the same and the first deaths occurred on the 6th day ( Fig. 3d) , but in three experiments the first deaths were on the 8th, 11th and 14th day ( Fig. 3a-c) . The longer time to death was due to a slower rate of growth from the 2 hr. count, and not to a smaller inoculum.
These approximately parallel curves ( Fig. 2 ) suggest that with a virulent strain the rate of increase is the same for all inocula; that the time of death depends on organisms. The first viable count on day 1 was carried out 2 hr. after the mice were dead; this count is called the 'infecting dose' and is about 1 log unit less than the inoculum as about 90 % of the inoculum spills over from the brain and is lost. Intracerebral pertussis infections in mice 209 the size of the inoculum; and that the longer the time to death, the lower the terminal count, which was 10 81 at 5 days and 10 7 ' 4 at 11 days. The growth of a virulent strain in the brain is rather different from the growth in the lung (Dolby, Thow & Standfast, 1961) . Small inocula of virulent intranasal strains increase and then decline, producing a sublethal infection. Infection by a virulent intracerebral strain, if growth occurs, is always lethal. Thus, the smallest inoculum in the series of experiments shown in Fig. 2, c . 30 viable organisms, eventually reached the lethal level at 11 days. Fig. 4 10 s Bordetella pertussis. In these three experiments, the first deaths were recorded on the 8th, curve a, 11th, curve 6, and 14th, curve c, days. Curve d (from Fig. 2) , with the first death on the 6th day, is the usually found curve for doses c. . There is no decline in the viable count from the 6th day as in lungs during sublethal infection, or in the brain during the sublethal infection investigated by Blyth (1955) or Andersen (1957) with other strains of B. pertussis and other strains of mice.
Mice were injected with a suspension calculated to contain three organisms or less and 5 mice were killed daily from the 2nd to the 14th day. Three positive counts were obtained; on the 3rd day 10 , forming a growth curve similar to those of larger doses; the remainder of the brains were sterile. Our figures are consistent with the hypothesis that the smallest inoculum that begins to grow in the brain will multiply eventually to a lethal level. 
Sterile brains
Corroborative evidence that there is no decrease in viable count is shown in Table 1 . Though the percentage of sterile brains varies with the infecting dose, the percentage of sterile brains in the cumulative series for a given dose remains remarkably constant from the 5th day to the 14th day. There is no rise in the percentage of sterile brains, as would happen if the mice were freeing themselves of the infecting organism. 
Terminal count in infected mice
The terminal viable count was approximately constant at c. 10 8 regardless of the infecting dose (Fig. 5) . The figures given for each infecting dose show the highest individual count and the lower individual count of any mouse given that dose. Although the terminal count did not vary with the infecting dose, it tended to fall as the time to death increased (see also Figs. 2-4) .
In infected mice which failed to respond to or benefit from serum or vaccine treatment, the terminal count was of the same order as normal mice given the same infecting dose. In mice which responded to treatment, of course, the brain counts were well below the lethal level. Fig. 6 shows the mean terminal counts for groups of control mice, vaccinated mice and serum treated mice. The terminal count falls with time in all three groups suggesting that the 'lethal toxins' from an infecting dose that increased from 10 2 ' 5 to 10 6 ' 8 in 9 days have the same lethal effect on the 9th day as those from the dose that grew from 10 2 ' 5 to 10 7 ' 8 in 6 days have on the 6th day.
Toxic dose
Mice are more susceptible to B. pertitssis toxin administered by the intracerebral route than by any other route. The TD 50 (toxic dose killing 50 % of mice) of toxin preparation no. 5353 was 0-125/* by the intracerebral route, 1-3/t by the intraperitoneal route. The TD50 IG of this toxin (no. 5353) was contained in 10 7 ' 5 bacterial cells; the TD50 IG for eight other toxin preparations were contained in 8-3 x 10 7 to 5-5 x 10 9 bacterial cells, numbers which are similar to the terminal count of c. 10
Sections of brains of infected mice at 6 days, just before death, look very similar to those of mice which have received a lethal dose of toxin intracerebrally. The matrix of the cerebral hemispheres has disintegrated, the nuclei of the astrocytes and oligodendrocytes have disappeared and red blood cells, granulocytes and small round cells with strongly staining nuclei are scattered throughout the section. At about the 4th day after infection, the Purkinje cells of the cerebellum begin to lose their staining properties.
If death is due to toxin, antitoxin given intracerebrally should be protective. However, samples of our antitoxin injected into the brain 2, 3, 4 and 5 days after infection were without effect, either in increased survival time or in raised terminal counts.
Intracerebral infection in passively protected mice The course of an intracerebral infection was followed in groups of mice given potent 'intracerebral' pertussis antisera by the intraperitoneal route 3 days (Fig. 7) or 4 hr. (Fig. 8 ) before, and 1 day or 3 days ( Fig. 9) after the challenge given by the intracerebral route.
The results were similar in all cases. The count in the treated mice was of the same order as the controls until the 3rd or 4th day after infection when it fell at a rate depending on the strength and time of administration of the serum. The serum was equally effective given before or up to 3 days after the challenge.
' Intracerebral' serum, whenever given, did not reduce the number of bacteria in the brain until the 3rd or 4th day after infection; this was quite unlike the immediate reduction in numbers of organisms observed in the serum treatment of intranasal infection .
The independence of the 3-to 4-day lag and the time of administration of the serum relative to the time of infection appears to be due to the inaccessibility of the brain lesion to circulating antibody until the infection has reached a certain stage, at about 3-4 days (Holt, Spasojevic, Dolby & Standfast, 1961) . Treated mice were given anti-pertussis rabbit serum by the intraperitoneal route 3 days before the challenge dose which was given by the intracerebral route. In this experiment 18 out of 20 mice survived at least 14 days in the treated mice and 1 out of 30 survived the 7th day in the controls. Fig. 8 . Similar growth curves in mice given anti-pertussis rabbit serum 4 hr. before the challenge. Seventy-two out of 80 mice survived at least until the 13th day in the treated group and 2 out of 30 survived the 6th day in the controls. Fig. 9 . Growth curves in mice given anti-pertussis rabbit serum 1 day or 3 days after challenge. In the controls no mouse survived the 5th day. In the treated mice 18 out of 20 survived at least 12 days if given serum 1 day after the challenge and 15 out of 20 survived at least 6 days if given the serum 3 days after the challenge. Each point on these graphs is the geometric mean of 5 or 10 mice.
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Intracerebral infections in actively immunized mice
The growth of organisms in the brains of actively immunized mice is very like that in passively protected mice. Mice were given a single dose of vaccine of either 80, 400 or 2000 million organisms, and challenged with 50,000 B. pertussis, strain 18-323 ( Fig. 10 . Growth curves of Bordetella pertussis in mice actively immunized with killed pertussis vaccines at three dose levels, 80, 400, and 2000 million, 14 days before challenge by the intracerebral route. The 30 control unvaccinated mice all died on the 6th or 7th day after challenge; 27 out of 30 mice given 80 million bacilli as vaccine died on the 6th or 8th day; 11 out of 29 mice given 400 million died on the 6th or 8th day and 5 out of 29 mice given 2000 million. There were no more deaths up to the 14th day when the experiment was terminated. No counts were done after the 8th day by which time the count was falling steadily in the surviving mice. Open circles (O) represent living mice, closed circles (•) dead mice.
DISCUSSION AND CONCLUSIONS
The family of curves obtained for infection with different doses show that the infecting organisms increase at a rate that was constant for all doses in 29/32 instances. The rate of growth in three instances was slower than expected for the infecting dose, though the terminal count for the mouse dying first was that expected. Since the infecting dose was known, the longer time to death 10-14 days instead of 6 days must have been due to the slower growth of the organisms. This slower growth also occurred in passively protected mice (Figs. 7-9 ) during the first 3 or 4 days of infection, although the striking effect of the serum is not seen until after the 4th day. It is least evident (between the 3rd and 4th days, Fig. 9 ) in mice given serum 3 days after challenge, when the count is already more than 216 JEAN M. DOLBY AND A. F. B. STANDFAST SUMMARY The growth of virulent strains of Bordetella pertussis in the brains of mice was studied by carrying out viable counts on mice killed at various times during the infection. The results suggested that this system conformed to the general model which postulates that the organisms causing death multiply in vivo at a rate which is constant for all doses and that death is certain to occur when the number of organisms reaches a certain constant figure. Perhaps the most important factor in this route of infection is the lodgement of the parasite in the host, for if this is accomplished a single organism grows until the lethal level is reached. There is no sublethal infection.
In actively and passively protected mice, the growth of the organism is approximately the same as in unprotected controls for the first 4-5 days. At this time there is a striking change in protected animals and the viable count falls rapidly and progressively and the animals survive. At the same time the blood-brain barrier becomes permeable and circulating antibodies diffuse into the brain. In vitro, specific antisera plus complement are highly bactericidal.
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